Soluble CD138/Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer.

Mohammad Nabi Sanaee,Mahyar Malekzadeh,Abdolaziz Khezri,Abbas Ghaderi,Mehrnoosh Doroudchi

Soluble CD138/Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer.

2014

Mohammad Nabi Sanaee
Mahyar Malekzadeh
Abdolaziz Khezri
Abbas Ghaderi
Mehrnoosh Doroudchi

Background: CD138/Syndecan-1 (Sdc-1) is expressed on the tumor and stromal cells of invasive bladder carcinoma. CD138/Sdc-1 shedding from the cell surface is asso

Keywords:

Carcinoma
Urology
Cell
Syndecan 1
Cancer research
Stromal cell
Cellular differentiation
Downregulation and upregulation
Bladder cancer
Neoplasm Grading
Oncology
Internal medicine
Medicine
Case-control study
Immunology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations